retatrutide
ProductHeard on podcasts recently
An investigational once-weekly medication that activates GLP-1, GIP, and glucagon receptors and is being studied for obesity, diabetes, and related metabolic conditions.
Discussed inHealth & Science100%
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of retatrutide per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 12 | 0.04‰ | 1 |
| Sep 1 | 0.03‰ | 1 |
| Sep 3 | 0.12‰ | 3 |
| Sep 8 | 0.14‰ | 1 |
| Sep 21 | 0.03‰ | 1 |
Discussed alongside
Names that come up in the same conversations as retatrutide.
Embed this
Paste this on your site to show retatrutide's current trend:
<iframe src="https://podlume.ai/embed/e/product-retatrutide" width="360" height="220" style="border:0" loading="lazy" title="retatrutide on PodLume Trends"></iframe>